APT Medical's (SHA:688617) net profit attributable to shareholders in 2024 rose 26% to 673.2 million yuan from 533.9 million yuan a year earlier, according to a Wednesday filing with the Shanghai Stock Exchange.
Earnings per share climbed 27% year on year to 6.92 yuan from 5.46 yuan.
The Chinese medical device company's operating income in the same period inched 25% higher to 2.07 billion yuan from 1.65 billion yuan in the previous year, the filing said.
The company's shares dropped 4% in recent trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。